This page lists the SEC filings reported by GALEN PARTNERS III L P.
Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13D/A | 2007-05-11 | GALEN PARTNERS III L P | DERMA SCIENCES, INC. | 3,510,547 | 12.6% | EDGAR |
SC 13D/A | 2006-11-13 | GALEN PARTNERS III L P | ENCORE MEDICAL CORP | - | - | EDGAR |
SC 13D/A | 2006-07-12 | GALEN PARTNERS III L P | ENCORE MEDICAL CORP | - | - | EDGAR |
SC 13D/A | 2005-12-05 | GALEN PARTNERS III L P | SPECIALIZED HEALTH PRODUCTS INTERNATIONAL INC | - | - | EDGAR |
SC 13D/A | 2005-08-12 | GALEN PARTNERS III L P | DAOU SYSTEMS INC | 5,227,256 | 18.9% | EDGAR |
SC 13G | 2005-02-14 | GALEN PARTNERS III L P | ESSENTIAL GROUP INC | 1,598,874 | 26.9% | EDGAR |
SC 13D/A | 2005-02-08 | GALEN PARTNERS III L P | DERMA SCIENCES, INC. | - | 35.1% | EDGAR |
SC 13D/A | 2005-02-02 | GALEN PARTNERS III L P | DERMA SCIENCES, INC. | - | 35.4% | EDGAR |
SC 13D/A | 2004-01-13 | GALEN PARTNERS III L P | ENCORE MEDICAL CORP | - | - | EDGAR |
SC 13D/A | 2003-06-23 | GALEN PARTNERS III L P | DERMA SCIENCES INC | 4,890,201 | 46.6% | EDGAR |
SC 13D/A | 2003-05-27 | GALEN PARTNERS III L P | DERMA SCIENCES INC | 4,702,920 | 45.7% | EDGAR |
SC 13D | 2003-04-04 | GALEN PARTNERS III L P | ACURA PHARMACEUTICALS, INC | - | - | EDGAR |
SC 13D/A | 2002-08-20 | GALEN PARTNERS III L P | SPECIALIZED HEALTH PRODUCTS INTERNATIONAL INC | 1,258,457 | - | EDGAR |
SC 13D/A | 2002-03-06 | GALEN PARTNERS III L P | DERMA SCIENCES INC | 4,145,640 | 59.5% | EDGAR |
SC 13D | 2001-11-16 | GALEN PARTNERS III L P | SPECIALIZED HEALTH PRODUCTS INTERNATIONAL INC | 1,263,874 | - | EDGAR |
SC 13D | 2001-06-20 | GALEN PARTNERS III L P | ENCORE MEDICAL CORP | 1,011,633 | - | EDGAR |
SC 13D/A | 2001-04-11 | GALEN PARTNERS III L P | Q MED INC | 3,865,214 | 25.2% | EDGAR |
SC 13D/A | 2001-03-19 | GALEN PARTNERS III L P | DERMA SCIENCES INC | 3,241,462 | 57.2% | EDGAR |
SC 13D/A | 2000-11-15 | - | - | - | - | EDGAR |
SC 13D/A | 2000-08-07 | - | - | - | - | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.